{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:04:09Z","timestamp":1789470249654,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Radiol"],"DOI":"10.1007\/s00247-026-06642-x","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T08:38:04Z","timestamp":1779525484000},"page":"2162-2175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Imaging findings in pediatric interferonopathies"],"prefix":"10.1007","volume":"56","author":[{"given":"Yuko","family":"Tsujioka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ok Hwa","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AnnaCarin","family":"Horne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Jinzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,23]]},"reference":[{"key":"6642_CR1","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","volume":"50","author":"HM Lazear","year":"2019","unstructured":"Lazear HM, Schoggins JW, Diamond MS (2019) Shared and distinct functions of type I and type III interferons. Immunity 50:907\u2013923","journal-title":"Immunity"},{"key":"6642_CR2","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab F, Mayer-Barber K, Sher A et al (2015) Type I interferons in infectious disease. Nat Rev Immunol 15:87\u2013103","journal-title":"Nat Rev Immunol"},{"key":"6642_CR3","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41577-021-00633-9","volume":"22","author":"YJ Crow","year":"2022","unstructured":"Crow YJ, Stetson DB (2022) The type I interferonopathies: 10 years on. Nat Rev Immunol 22:471\u2013483","journal-title":"Nat Rev Immunol"},{"key":"6642_CR4","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1084\/jem.20161596","volume":"213","author":"MP Rodero","year":"2016","unstructured":"Rodero MP, Crow YJ (2016) Type I interferon-mediated monogenic autoinflammation: the type I interferonopathies, a conceptual overview. J Exp Med 213:2527\u20132538","journal-title":"J Exp Med"},{"key":"6642_CR5","doi-asserted-by":"publisher","DOI":"10.70962\/jhi.20250003","volume":"1","author":"MC Poli","year":"2025","unstructured":"Poli MC, Aksentijevich I, Bousfiha AA et al (2025) Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee. J Hum Immunol 1:e20250003","journal-title":"J Hum Immunol"},{"key":"6642_CR6","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s13555-021-00517-9","volume":"11","author":"PJ G\u00f3mez-Arias","year":"2021","unstructured":"G\u00f3mez-Arias PJ, G\u00f3mez-Garc\u00eda F, Hern\u00e1ndez-Parada J et al (2021) Efficacy and safety of Janus kinase inhibitors in type I interferon-mediated monogenic autoinflammatory disorders: a scoping review. Dermatol Ther (Heidelb) 11:733\u2013750","journal-title":"Dermatol Ther (Heidelb)"},{"key":"6642_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.825367","volume":"13","author":"W Li","year":"2022","unstructured":"Li W, Wang W, Wang W et al (2022) Janus kinase inhibitors in the treatment of type I interferonopathies: a case series from a single center in China. Front Immunol 13:825367","journal-title":"Front Immunol"},{"key":"6642_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/sji.13314","volume":"98","author":"A Liu","year":"2023","unstructured":"Liu A, Ying S (2023) Aicardi-Gouti\u00e8res syndrome: a monogenic type I interferonopathy. Scand J Immunol 98:e13314","journal-title":"Scand J Immunol"},{"key":"6642_CR9","unstructured":"Crow YJ (1993) Aicardi-Gouti\u00e8res syndrome. In: GeneReviews\u00ae [Internet]. University of Washington"},{"key":"6642_CR10","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3174\/ajnr.A1694","volume":"30","author":"C Uggetti","year":"2009","unstructured":"Uggetti C, La Piana R, Orcesi S et al (2009) Aicardi-Gouti\u00e8res syndrome: neuroradiologic findings and follow-up. AJNR Am J Neuroradiol 30:1971\u20131976","journal-title":"AJNR Am J Neuroradiol"},{"key":"6642_CR11","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1177\/0883073814562252","volume":"30","author":"A Vanderver","year":"2015","unstructured":"Vanderver A, Prust M, Kadom N et al (2015) Early-onset Aicardi-Gouti\u00e8res syndrome: magnetic resonance imaging (MRI) pattern recognition: magnetic resonance imaging (MRI) pattern recognition. J Child Neurol 30:1343\u20131348","journal-title":"J Child Neurol"},{"key":"6642_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1212\/WNL.0000000000002228","volume":"86","author":"R La Piana","year":"2016","unstructured":"La Piana R, Uggetti C, Roncarolo F et al (2016) Neuroradiologic patterns and novel imaging findings in Aicardi-Gouti\u00e8res syndrome. Neurology 86:28\u201335","journal-title":"Neurology"},{"key":"6642_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2024.108578","volume":"143","author":"I Peixoto de Barcelos","year":"2024","unstructured":"Peixoto de Barcelos I, Jan AK, Modesti N et al (2024) Systemic complications of Aicardi Gouti\u00e8res syndrome using real-world data. Mol Genet Metab 143:108578","journal-title":"Mol Genet Metab"},{"key":"6642_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ajmg.a.36887","volume":"167A","author":"YJ Crow","year":"2015","unstructured":"Crow YJ, Chase DS, Lowenstein Schmidt J et al (2015) Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1. Am J Med Genet A 167A:296\u2013312","journal-title":"Am J Med Genet A"},{"key":"6642_CR15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/BF00972817","volume":"1","author":"EB Singleton","year":"1973","unstructured":"Singleton EB, Merten DF (1973) An unusual syndrome of widened medullary cavities of the metacarpals and phalanges, aortic calcification and abnormal dentition. Pediatr Radiol 1:2\u20137","journal-title":"Pediatr Radiol"},{"key":"6642_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10875-018-0572-1","volume":"39","author":"CR Ferreira","year":"2019","unstructured":"Ferreira CR, Crow YJ, Gahl WA et al (2019) DDX58 and classic Singleton-Merten syndrome. J Clin Immunol 39:75\u201380","journal-title":"J Clin Immunol"},{"key":"6642_CR17","volume":"14","author":"YM Alzahrani","year":"2022","unstructured":"Alzahrani YM, Alamoudi AA, Nahar NK, Albar RF (2022) Early-age manifestation of singleton Merten syndrome with systemic lupus erythematosus features: a case report. Cureus 14:e25244","journal-title":"Cureus"},{"key":"6642_CR18","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/ajmg.a.35732","volume":"161A","author":"A Feigenbaum","year":"2013","unstructured":"Feigenbaum A, M\u00fcller C, Yale C et al (2013) Singleton-Merten syndrome: an autosomal dominant disorder with variable expression. Am J Med Genet A 161A:360\u2013370","journal-title":"Am J Med Genet A"},{"key":"6642_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.21037\/atm-20-6198","volume":"9","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang F, Zhang X (2021) STING-associated vasculopathy with onset in infancy: a familial case series report and literature review. Ann Transl Med 9:176","journal-title":"Ann Transl Med"},{"key":"6642_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.104866","volume":"299","author":"SD Chauvin","year":"2023","unstructured":"Chauvin SD, Stinson WA, Platt DJ et al (2023) Regulation of cGAS and STING signaling during inflammation and infection. J Biol Chem 299:104866","journal-title":"J Biol Chem"},{"key":"6642_CR21","doi-asserted-by":"publisher","first-page":"575219","DOI":"10.3389\/fimmu.2020.575219","volume":"11","author":"F Staels","year":"2020","unstructured":"Staels F, Betrains A, Doubel P et al (2020) Adult-onset ANCA-associated vasculitis in SAVI: extension of the phenotypic spectrum, case report and review of the literature. Front Immunol 11:575219","journal-title":"Front Immunol"},{"key":"6642_CR22","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jaip.2020.11.007","volume":"9","author":"ML Fr\u00e9mond","year":"2021","unstructured":"Fr\u00e9mond ML, Hadchouel A, Berteloot L et al (2021) Overview of STING-associated vasculopathy with onset in infancy (SAVI) among 21 patients. J Allergy Clin Immunol Pract 9:803-818.e11","journal-title":"J Allergy Clin Immunol Pract"},{"key":"6642_CR23","doi-asserted-by":"publisher","first-page":"e31832","DOI":"10.1097\/MD.0000000000031832","volume":"101","author":"D Shen","year":"2022","unstructured":"Shen D, Fan X, Zhou Q et al (2022) Use of tofacitinib for infant-onset STING-associated vasculopathy: a case report from China. Medicine (Baltimore) 101:e31832","journal-title":"Medicine (Baltimore)"},{"key":"6642_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1312625","volume":"371","author":"Y Liu","year":"2014","unstructured":"Liu Y, Jesus AA, Marrero B et al (2014) Activated STING in a vascular and pulmonary syndrome. N Engl J Med 371:507\u2013518","journal-title":"N Engl J Med"},{"key":"6642_CR25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/cells11030318","volume":"11","author":"C David","year":"2022","unstructured":"David C, Fr\u00e9mond ML (2022) Lung inflammation in STING-associated vasculopathy with onset in infancy (SAVI). Cells 11:318","journal-title":"Cells"},{"key":"6642_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.577918","volume":"8","author":"Y Dai","year":"2020","unstructured":"Dai Y, Liu X, Zhao Z et al (2020) Stimulator of interferon genes-associated vasculopathy with onset in infancy: a systematic review of case reports. Front Pediatr 8:577918","journal-title":"Front Pediatr"},{"key":"6642_CR27","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s10875-019-00690-9","volume":"40","author":"X Tang","year":"2020","unstructured":"Tang X, Xu H, Zhou C et al (2020) STING-associated vasculopathy with onset in infancy in three children with new clinical aspect and unsatisfactory therapeutic responses to tofacitinib. J Clin Immunol 40:114\u2013122","journal-title":"J Clin Immunol"},{"key":"6642_CR28","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s10875-023-01431-9","volume":"43","author":"C Ladoux","year":"2023","unstructured":"Ladoux C, Pasquet M, Crow YJ et al (2023) STING-associated vasculopathy with onset in infancy (SAVI) presenting as massive intra alveolar hemorrhage. J Clin Immunol 43:699\u2013702","journal-title":"J Clin Immunol"},{"key":"6642_CR29","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ng.3279","volume":"47","author":"LB Watkin","year":"2015","unstructured":"Watkin LB, Jessen B, Wiszniewski W et al (2015) COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis. Nat Genet 47:654\u2013660","journal-title":"Nat Genet"},{"key":"6642_CR30","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10875-016-0271-8","volume":"36","author":"TJ Vece","year":"2016","unstructured":"Vece TJ, Watkin LB, Nicholas S et al (2016) Copa syndrome: a novel autosomal dominant immune dysregulatory disease. J Clin Immunol 36:377\u2013387","journal-title":"J Clin Immunol"},{"key":"6642_CR31","doi-asserted-by":"publisher","first-page":"00017","DOI":"10.1183\/23120541.00017-2018","volume":"4","author":"JL Tsui","year":"2018","unstructured":"Tsui JL, Estrada OA, Deng Z et al (2018) Analysis of pulmonary features and treatment approaches in the COPA syndrome. ERJ Open Res 4:00017\u201302018","journal-title":"ERJ Open Res"},{"key":"6642_CR32","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1007\/s00247-023-05600-1","volume":"53","author":"HN Nguyen","year":"2023","unstructured":"Nguyen HN, Salman R, Vogel TP et al (2023) Imaging findings of COPA syndrome. Pediatr Radiol 53:844\u2013853","journal-title":"Pediatr Radiol"},{"key":"6642_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s10875-016-0252-y","volume":"36","author":"TA Briggs","year":"2016","unstructured":"Briggs TA, Rice GI, Adib N et al (2016) Spondyloenchondrodysplasia due to mutations in ACP5: a comprehensive survey. J Clin Immunol 36:220\u2013234","journal-title":"J Clin Immunol"},{"key":"6642_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/ng.748","volume":"43","author":"TA Briggs","year":"2011","unstructured":"Briggs TA, Rice GI, Daly S et al (2011) Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signature. Nat Genet 43:127\u2013131","journal-title":"Nat Genet"},{"key":"6642_CR35","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s00431-025-05982-4","volume":"184","author":"E Pekpak \u015eahino\u011flu","year":"2025","unstructured":"Pekpak \u015eahino\u011flu E, Oren AC, \u015eahino\u011flu B et al (2025) Clinical, laboratory, and molecular characteristics of patients with spondyloenchondrodysplasia: a case series study. Eur J Pediatr 184:152","journal-title":"Eur J Pediatr"},{"key":"6642_CR36","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00438-023-02009-1","volume":"298","author":"RM Elhossini","year":"2023","unstructured":"Elhossini RM, Elbendary HM, Rafat K et al (2023) Spondyloenchondrodysplasia in five new patients: identification of three novel ACP5 variants with variable neurological presentations. Mol Genet Genomics 298:709\u2013720","journal-title":"Mol Genet Genomics"},{"key":"6642_CR37","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1084\/jem.20151529","volume":"213","author":"MEC Meuwissen","year":"2016","unstructured":"Meuwissen MEC, Schot R, Buta S et al (2016) Human USP18 deficiency underlies type 1 interferonopathy leading to severe pseudo-TORCH syndrome. J Exp Med 213:1163\u20131174","journal-title":"J Exp Med"},{"key":"6642_CR38","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1056\/NEJMoa1905633","volume":"382","author":"F Alsohime","year":"2020","unstructured":"Alsohime F, Martin-Fernandez M, Temsah MH et al (2020) JAK inhibitor therapy in a child with inherited USP18 deficiency. N Engl J Med 382:256\u2013265","journal-title":"N Engl J Med"},{"key":"6642_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-00985-0","volume":"23","author":"A Charras","year":"2021","unstructured":"Charras A, Smith E, Hedrich CM (2021) Systemic lupus erythematosus in children and young people. Curr Rheumatol Rep 23:20","journal-title":"Curr Rheumatol Rep"},{"key":"6642_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/ar3531","volume":"13","author":"EC Baechler","year":"2011","unstructured":"Baechler EC, Bilgic H, Reed AM (2011) Type I interferon pathway in adult and juvenile dermatomyositis. Arthritis Res Ther 13:249","journal-title":"Arthritis Res Ther"},{"key":"6642_CR41","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/ng1782","volume":"38","author":"RR Graham","year":"2006","unstructured":"Graham RR, Kozyrev SV, Baechler EC et al (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38:550\u2013555","journal-title":"Nat Genet"},{"key":"6642_CR42","doi-asserted-by":"publisher","first-page":"e1000084","DOI":"10.1371\/journal.pgen.1000084","volume":"4","author":"KE Taylor","year":"2008","unstructured":"Taylor KE, Remmers EF, Lee AT et al (2008) Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus. PLoS Genet 4:e1000084","journal-title":"PLoS Genet"},{"key":"6642_CR43","doi-asserted-by":"publisher","first-page":"144","DOI":"10.3389\/fped.2018.00144","volume":"6","author":"G Costagliola","year":"2018","unstructured":"Costagliola G, Mosca M, Migliorini P, Consolini R (2018) Pediatric systemic lupus erythematosus: learning from longer follow up to adulthood. Front Pediatr 6:144","journal-title":"Front Pediatr"},{"key":"6642_CR44","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5152\/TurkArchPediatr.2024.24097","volume":"59","author":"P\u00d6 Avar-Ayd\u0131n","year":"2024","unstructured":"Avar-Ayd\u0131n P\u00d6, Brunner HI (2024) Revisiting childhood-onset systemic lupus erythematosus. Turk Arch Pediatr 59:336\u2013344","journal-title":"Turk Arch Pediatr"},{"key":"6642_CR45","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s00234-018-2130-1","volume":"61","author":"H Yeoh","year":"2019","unstructured":"Yeoh H, Lee JY, Lee YJ et al (2019) Relationship between cerebral microbleeds and white matter MR hyperintensities in systemic lupus erythematosus: a retrospective observational study. Neuroradiology 61:265\u2013274","journal-title":"Neuroradiology"},{"key":"6642_CR46","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/S2352-4642(22)00157-2","volume":"6","author":"S Appenzeller","year":"2022","unstructured":"Appenzeller S, Pereira DR, Julio PR et al (2022) Neuropsychiatric manifestations in childhood-onset systemic lupus erythematosus. Lancet Child Adolesc Health 6:571\u2013581","journal-title":"Lancet Child Adolesc Health"},{"key":"6642_CR47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4078\/jrd.2022.29.1.14","volume":"29","author":"JW Rhim","year":"2022","unstructured":"Rhim JW (2022) Juvenile dermatomyositis. J Rheum Dis 29:14\u201321","journal-title":"J Rheum Dis"},{"key":"6642_CR48","doi-asserted-by":"publisher","first-page":"e281","DOI":"10.1093\/rheumatology\/keae182","volume":"63","author":"HD Nguyen","year":"2024","unstructured":"Nguyen HD, Jouen F, D\u00e9chelotte B et al (2024) TIF1-gamma IgG2 isotype is not associated with malignancy in juvenile dermatomyositis patients. Rheumatology (Oxford) 63:e281\u2013e284","journal-title":"Rheumatology (Oxford)"},{"key":"6642_CR49","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1093\/rheumatology\/ker262","volume":"50","author":"WR Davis","year":"2011","unstructured":"Davis WR, Halls JE, Offiah AC et al (2011) Assessment of active inflammation in juvenile dermatomyositis: a novel magnetic resonance imaging-based scoring system. Rheumatology (Oxford) 50:2237\u20132244","journal-title":"Rheumatology (Oxford)"},{"key":"6642_CR50","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1080\/14397595.2018.1511026","volume":"29","author":"N Sakurai","year":"2019","unstructured":"Sakurai N, Hino-Shishikura A, Nozawa T et al (2019) Clinical significance of subcutaneous fat and fascial involvement in juvenile dermatomyositis. Mod Rheumatol 29:808\u2013813","journal-title":"Mod Rheumatol"},{"key":"6642_CR51","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1038\/s41390-024-03551-3","volume":"97","author":"P Vignesh","year":"2025","unstructured":"Vignesh P, Nadig PL, Basu S et al (2025) Profile of patients with juvenile dermatomyositis and anti-MDA5 autoantibodies. Pediatr Res 97:2020\u20132028","journal-title":"Pediatr Res"},{"key":"6642_CR52","doi-asserted-by":"crossref","unstructured":"Galbraith MD, Rachubinski AL, Smith KP et al (2023) Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition. Sci Adv 9:eadg6218","DOI":"10.1126\/sciadv.adg6218"},{"key":"6642_CR53","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10875-020-00803-9","volume":"40","author":"XF Kong","year":"2020","unstructured":"Kong XF, Worley L, Rinchai D et al (2020) Three copies of four interferon receptor genes underlie a mild type I interferonopathy in Down syndrome. J Clin Immunol 40:807\u2013819","journal-title":"J Clin Immunol"},{"key":"6642_CR54","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12969-021-00592-4","volume":"19","author":"JL Bloom","year":"2021","unstructured":"Bloom JL, Frank B, Weinman JP et al (2021) Diffuse alveolar hemorrhage in children with trisomy 21. Pediatr Rheumatol Online J 19:114","journal-title":"Pediatr Rheumatol Online J"}],"container-title":["Pediatric Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-026-06642-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00247-026-06642-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-026-06642-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:17:29Z","timestamp":1789467449000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00247-026-06642-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":54,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["6642"],"URL":"https:\/\/doi.org\/10.1007\/s00247-026-06642-x","relation":{},"ISSN":["1432-1998"],"issn-type":[{"value":"1432-1998","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,23]]},"assertion":[{"value":"31 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}